These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23159535)

  • 1. [Metformin in type 2 diabetes: what if we get it wrong?].
    Boussageon R
    Presse Med; 2013 Feb; 42(2):132-3. PubMed ID: 23159535
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin: the past, presence, and future.
    Alušík Š; Paluch Z
    Minerva Med; 2015 Aug; 106(4):233-8. PubMed ID: 25532538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
    Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo Segura M; Roqué i Figuls M; Moher D
    Cochrane Database Syst Rev; 2015 Sep; (9):CD002966. PubMed ID: 26421423
    [No Abstract]   [Full Text] [Related]  

  • 5. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin monotherapy vs. combination therapy.
    Ebell MH
    Am Fam Physician; 2005 Mar; 71(5):899. PubMed ID: 15768618
    [No Abstract]   [Full Text] [Related]  

  • 7. High levels of leptin are associated with poor self-rated health in men and women with type 2 diabetes treated with metformin.
    Andreasson AN; Carlsson AC; Wändell PE
    Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):e11-2. PubMed ID: 23337091
    [No Abstract]   [Full Text] [Related]  

  • 8. Sitagliptin/metformin (Janumet) for type 2 diabetes.
    Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
    [No Abstract]   [Full Text] [Related]  

  • 9. [++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].
    Janka HU
    Internist (Berl); 2000 Jul; 41(7):688-9. PubMed ID: 10929259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metformin in type 2 diabetes. An extensive observational study confirms the agent as first choice--so far].
    Rydén M
    Lakartidningen; 2011 Jan 26-Feb 1; 108(4):136. PubMed ID: 21365817
    [No Abstract]   [Full Text] [Related]  

  • 11. Sitagliptin.
    Drucker D; Easley C; Kirkpatrick P
    Nat Rev Drug Discov; 2007 Feb; 6(2):109-10. PubMed ID: 17342863
    [No Abstract]   [Full Text] [Related]  

  • 12. Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin.
    Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA
    Arch Intern Med; 2011 Jun; 171(11):1042-3; author reply 1043. PubMed ID: 21670379
    [No Abstract]   [Full Text] [Related]  

  • 13. Repurposing Metformin for Cardiovascular Disease.
    Rena G; Lang CC
    Circulation; 2018 Jan; 137(5):422-424. PubMed ID: 29378754
    [No Abstract]   [Full Text] [Related]  

  • 14. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
    Kanna B; Abreu-Pacheco H
    Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of type 2 diabetes with metformin].
    Amouyal C; Andreelli F
    Rev Prat; 2015 Dec; 65(10):1245-9. PubMed ID: 26979012
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 18. Pioglitazone/metformin (Actoplus met).
    Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
    [No Abstract]   [Full Text] [Related]  

  • 19. Considerations regarding the use of metformin with olanzapine.
    Alamiri B
    Am J Psychiatry; 2008 Sep; 165(9):1205-6; author reply 1207. PubMed ID: 18765498
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metformin and type 2 diabetes: the UKPDS experience].
    Leverve XM
    Journ Annu Diabetol Hotel Dieu; 2007; ():5-11. PubMed ID: 18610755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.